Filing Details
- Accession Number:
- 0001179110-16-017687
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2016-01-12 16:54:13
- Reporting Period:
- 2016-01-07
- Filing Date:
- 2016-01-12
- Accepted Time:
- 2016-01-12 16:54:13
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1586105 | Egalet Corp | EGLT | Pharmaceutical Preparations (2834) | 463575334 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1591113 | S Robert Radie | 1301 Joy Run Glenmoore PA 19343 | President And Ceo | Yes | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2016-01-07 | 3,000 | $9.61 | 286,900 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2016-01-08 | 4,000 | $9.69 | 282,900 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2016-01-11 | 3,000 | $9.65 | 279,900 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Footnotes
- Sale effected pursuant to a Rule 10b5-1 trading plan to pay tax liability on vesting restricted stock. The restricted stock was originally granted on February 11, 2014.
- The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $9.53 to $9.87, inclusive. The reportingperson undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full informationregarding the number of shares sold at each separate price within the range set forth in this footnote.
- The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $9.49 to $9.96, inclusive. The reportingperson undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full informationregarding the number of shares sold at each separate price within the range set forth in this footnote.
- The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $9.49 to $9.98, inclusive. The reportingperson undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full informationregarding the number of shares sold at each separate price within the range set forth in this footnote.
Billionaire Hedge Funds
